[caption id="attachment_5144" align="alignleft" width="260"] The MRS7145 photoactive drug is effective in animal models with Parkinson’s disease, according to the study published in the Journal of Controlled Release[/caption] An international team has designed the first potentially therapeutic photoactive drug –MRS7145– to fight Parkinson’s disease, according to the...
[caption id="attachment_4470" align="alignleft" width="300"] Per Svenningson, professor from Karolinska Instituet (Sweden).[/caption] The Eurolife Autumn Symposium took place on the 24th and 25th of October, and was organized by the University of Barcelona, the Institute of Neurosciences of the UB and the master’s degree in Neurosciences. Researcher Per...
The research group led by Dr Cristina Malagelada, from the Department of Biomedicine of the Faculty of Medicine and Health Sciences of the UB, has conducted a method to predict in which way dyskinesia will affect each patient with Parkinson’s. The group recently received a VALUNI...
A team of researchers of the Institute of Neurosciences of the University of Barcelona and the Institute for Bioengineering of Catalonia (IBEC) have identified a possible mechanism to slow the neurodegenerative progression of Parkinson’s disease. Parkinson’s neuronal degeneration is caused by Lewy bodies, abnormal aggregates created...